These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9256796)

  • 1. Acute care decisions--ethics in action.
    Haddad A
    RN; 1997 Jul; 60(7):17-20. PubMed ID: 9256796
    [No Abstract]   [Full Text] [Related]  

  • 2. [BRCA1 and BRCA2--breast cancer susceptibility genes].
    Dagan E; Gershoni-Baruch R
    Harefuah; 1997 Nov; 133(10):455-7. PubMed ID: 9418320
    [No Abstract]   [Full Text] [Related]  

  • 3. BRCA1. A new marker in the management of patients with breast cancer?
    Offit K
    Cancer; 1996 Feb; 77(4):599-601. PubMed ID: 8616748
    [No Abstract]   [Full Text] [Related]  

  • 4. The Brca1 and Brca2 proteins and tumor pathogenesis.
    Ingvarsson S
    Anticancer Res; 1999; 19(4B):2853-61. PubMed ID: 10652564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online.
    Claes K; Machackova E; De Vos M; Mortier G; De Paepe A; Messiaen L
    Hum Mutat; 1999; 13(3):256. PubMed ID: 10090482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer].
    Eisinger F; Alby N; Bremond A; Dauplat J; Espié M; Janiaud P; Kuttenn F; Lebrun JP; Lefranc JP; Pierret J; Sobol H; Stoppa-Lyonnet D; Thouvenin D; Tristant H; Feingold J
    Ann Genet; 1999; 42(1):51-64. PubMed ID: 10214508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Roles of BRCA1 and BRCA2 in DNA repair and tumor suppression].
    Yano K; Miki Y
    Tanpakushitsu Kakusan Koso; 2001 Jun; 46(8 Suppl):1055-62. PubMed ID: 11436293
    [No Abstract]   [Full Text] [Related]  

  • 8. More on breast cancer guidelines.
    Nassar BA; Ludman MD; Costa MT; Welch JP; Butts CA; Love JR; Hogg H; Beis MJ
    CMAJ; 1998 Jun; 158(11):1429; author reply 1429-30. PubMed ID: 9629100
    [No Abstract]   [Full Text] [Related]  

  • 9. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.
    Armes JE; Trute L; White D; Southey MC; Hammet F; Tesoriero A; Hutchins AM; Dite GS; McCredie MR; Giles GG; Hopper JL; Venter DJ
    Cancer Res; 1999 Apr; 59(8):2011-7. PubMed ID: 10213514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are BRCA1- and BRCA2-associated breast cancers different?
    Offit K
    J Clin Oncol; 2000 Nov; 18(21 Suppl):104S-6S. PubMed ID: 11060336
    [No Abstract]   [Full Text] [Related]  

  • 11. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient.
    Tsongalis GJ; Linfert DR; Johnson RC; Ackroyd R; Berman MM; Ricci A
    Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is hereditary predisposition to breast cancer linked to BRCA1 a disease of response to genotoxic lesions?].
    Feunteun J
    C R Seances Soc Biol Fil; 1998; 192(2):235-40. PubMed ID: 9759367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear location and cell cycle regulation of the BRCA2 protein.
    Bertwistle D; Swift S; Marston NJ; Jackson LE; Crossland S; Crompton MR; Marshall CJ; Ashworth A
    Cancer Res; 1997 Dec; 57(24):5485-8. PubMed ID: 9407955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited predisposition to breast cancer.
    Ponder BA
    Biochem Soc Symp; 1998; 63():223-30. PubMed ID: 9513726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.
    Yazici H; Bitisik O; Akisik E; Cabioglu N; Saip P; Muslumanoglu M; Glendon G; Bengisu E; Ozbilen S; Dincer M; Turkmen S; Andrulis IL; Dalay N; Ozcelik H
    Br J Cancer; 2000 Sep; 83(6):737-42. PubMed ID: 10952777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online.
    De Benedetti VM; Radice P; Pasini B; Stagi L; Pensotti V; Mondini P; Manoukian S; Conti A; Spatti G; Rilke F; Pierotti MA
    Hum Mutat; 1998; 12(3):215. PubMed ID: 10660329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten novel BRCA1 and BRCA2 mutations in breast and/or ovarian cancer families from northern Germany.
    Kiechle M; Gross E; Schwarz-Boeger U; Pfisterer J; Jonat W; Gerber WD; Albacht B; Fischer B; Schlegelberger B; Arnold N
    Hum Mutat; 2000 Dec; 16(6):529-30. PubMed ID: 11102986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1/BRCA2 in breast-conserving therapy.
    Turner BC; Glazer PM; Haffty BG
    J Clin Oncol; 1999 Nov; 17(11):3689. PubMed ID: 10550169
    [No Abstract]   [Full Text] [Related]  

  • 19. [From gene to disease; from BRCA1 OR BRCA2 to breast cancer].
    Van den Ouweland AM
    Ned Tijdschr Geneeskd; 2001 Jun; 145(25):1228. PubMed ID: 11447881
    [No Abstract]   [Full Text] [Related]  

  • 20. Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2.
    Foray N; Randrianarison V; Marot D; Perricaudet M; Lenoir G; Feunteun J
    Oncogene; 1999 Dec; 18(51):7334-42. PubMed ID: 10602489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.